Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

C-Path welcomes Kay Holcombe to its Board of Directors

January 17, 2018 TUCSON, Ariz., January 17, 2018 — The Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to i

January 1, 2018

Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the Functional Dyspepsia Symptom Diary (FDSD)

Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs

Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition

December 22, 2017

A Dynamic Map for Learning, Communicating, Navigating and Improving Therapeutic Development

December 22, 2017

Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development

Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure

C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)

Tucson, AZ – December 18, 2017 Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

December 8, 2017

Characterizing Disease Progression for Parkinson’s Disease to implement efficient trial designs

December 8, 2017

Model-Informed Biomarker Qualification: Alzheimer and Parkinson Disease Imaging Biomarkers

Previous6162 63...109 Next